# Eve Holding, Inc.: financial statements, quarterly

EVEX · NYSE · CIK 1823652 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/evex.md) · [Financials](/companies/evex/financials.md) · [Filings](/companies/evex/filings.md) · [Insiders](/companies/evex/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/evex/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Research and development | $m | [28.6](/filings/0001554855-24-000734.md) | [33.6 d](/filings/0001554855-26-000300.md) | [27.5](/filings/0001554855-25-000468.md) | [36.3](/filings/0001554855-25-000899.md) | [32.4](/filings/0001554855-25-001920.md) | [33.7 d](/filings/0001554855-26-000300.md) | [44.7](/filings/0001554855-26-000876.md) | [45.7](/filings/0001554855-26-001685.md) | [44.9](/filings/0001554855-25-001920.md) | [59.4 d](/filings/0001554855-26-000300.md) | [59.1](/filings/0001554855-26-000876.md) | [28.9](/filings/0001554855-26-001685.md) |
| Selling, general and administrative | $m | [5.0](/filings/0001554855-24-000734.md) | [5.3 d](/filings/0001554855-26-000300.md) | [6.5](/filings/0001554855-25-000468.md) | [5.4](/filings/0001554855-25-000899.md) | [8.4](/filings/0001554855-25-001920.md) | [6.2 d](/filings/0001554855-26-000300.md) | [7.9](/filings/0001554855-26-000876.md) | [8.2](/filings/0001554855-26-001685.md) | [7.0](/filings/0001554855-25-001920.md) | [7.6 d](/filings/0001554855-26-000300.md) | [7.2](/filings/0001554855-26-000876.md) | [8.3](/filings/0001554855-26-001685.md) |
| Operating income | $m | [(33.7)](/filings/0001554855-24-000734.md) | [(40.7) d](/filings/0001554855-26-000300.md) | [(33.9)](/filings/0001554855-25-000468.md) | [(41.7)](/filings/0001554855-25-000899.md) | [(40.8)](/filings/0001554855-25-001920.md) | [(39.9) d](/filings/0001554855-26-000300.md) | [(52.6)](/filings/0001554855-26-000876.md) | [(53.9)](/filings/0001554855-26-001685.md) | [(51.9)](/filings/0001554855-25-001920.md) | [(67.0) d](/filings/0001554855-26-000300.md) | [(66.3)](/filings/0001554855-26-000876.md) | [(37.2)](/filings/0001554855-26-001685.md) |
| Interest expense | $m | [0.0](/filings/0001554855-24-000734.md) | [0.2 d](/filings/0001554855-26-000300.md) | [0.4](/filings/0001554855-25-000468.md) | [0.6](/filings/0001554855-25-000899.md) | [0.8](/filings/0001554855-25-001920.md) | [1.8 d](/filings/0001554855-26-000300.md) | [2.2](/filings/0001554855-26-000876.md) | [2.4](/filings/0001554855-26-001685.md) | [2.7](/filings/0001554855-25-001920.md) | [2.8 d](/filings/0001554855-26-000300.md) | [4.6](/filings/0001554855-26-000876.md) | [5.2](/filings/0001554855-26-001685.md) |
| Income tax | $m | [1.1](/filings/0001554855-24-000734.md) | [(0.0) d](/filings/0001554855-26-000300.md) | [0.6](/filings/0001554855-25-000468.md) | [0.4](/filings/0001554855-25-000899.md) | [0.4](/filings/0001554855-25-001920.md) | [(0.9) d](/filings/0001554855-26-000300.md) | [(0.6)](/filings/0001554855-26-000876.md) | [0.4](/filings/0001554855-26-001685.md) | [1.2](/filings/0001554855-25-001920.md) | [(0.1) d](/filings/0001554855-26-000300.md) | [0.1](/filings/0001554855-26-000876.md) | [(2.9)](/filings/0001554855-26-001685.md) |
| Net income | $m | [(31.2)](/filings/0001554855-24-000734.md) | [(39.3) d](/filings/0001554855-26-000300.md) | [(25.3)](/filings/0001554855-25-001920.md) | [(36.4)](/filings/0001554855-25-001920.md) | [(35.8)](/filings/0001554855-25-001920.md) | [(40.7) d](/filings/0001554855-26-000300.md) | [(48.8)](/filings/0001554855-26-001685.md) | [(64.7)](/filings/0001554855-26-001685.md) | [(46.9)](/filings/0001554855-25-001920.md) | [(63.9) d](/filings/0001554855-26-000300.md) | [(68.8)](/filings/0001554855-26-001685.md) | [(34.2)](/filings/0001554855-26-001685.md) |
| Diluted EPS | $ per share | [(0.11)](/filings/0001554855-24-000734.md) | not reported | [(0.09)](/filings/0001554855-25-000468.md) | [(0.13)](/filings/0001554855-25-000899.md) | [(0.12)](/filings/0001554855-25-001920.md) | not reported | [(0.16)](/filings/0001554855-26-000876.md) | [(0.21)](/filings/0001554855-26-001685.md) | [(0.14)](/filings/0001554855-25-001920.md) | not reported | [(0.20)](/filings/0001554855-26-000876.md) | [(0.10)](/filings/0001554855-26-001685.md) |
| Basic EPS | $ per share | [(0.11)](/filings/0001554855-24-000734.md) | not reported | [(0.09)](/filings/0001554855-25-000468.md) | [(0.13)](/filings/0001554855-25-000899.md) | [(0.12)](/filings/0001554855-25-001920.md) | not reported | [(0.16)](/filings/0001554855-26-000876.md) | [(0.21)](/filings/0001554855-26-001685.md) | [(0.14)](/filings/0001554855-25-001920.md) | not reported | [(0.20)](/filings/0001554855-26-000876.md) | [(0.10)](/filings/0001554855-26-001685.md) |

- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [10.1](/filings/0001554855-23-000725.md) | [46.9](/filings/0001554855-25-000157.md) | [23.6](/filings/0001554855-24-000334.md) | [27.8](/filings/0001554855-24-000621.md) | [24.6](/filings/0001554855-24-000734.md) | [56.4](/filings/0001554855-26-000300.md) | [59.5](/filings/0001554855-25-000468.md) | [41.5](/filings/0001554855-25-000899.md) | [65.8](/filings/0001554855-25-001920.md) | [103](/filings/0001554855-26-001685.md) | [121](/filings/0001554855-26-000876.md) | [52.2](/filings/0001554855-26-001685.md) |
| Current assets | $m | [260](/filings/0001554855-23-000725.md) | [242](/filings/0001554855-25-000157.md) | [224](/filings/0001554855-24-000334.md) | [210](/filings/0001554855-24-000621.md) | [286](/filings/0001554855-24-000734.md) | [313](/filings/0001554855-26-000300.md) | [298](/filings/0001554855-25-000468.md) | [250](/filings/0001554855-25-000899.md) | [425](/filings/0001554855-25-001920.md) | [411](/filings/0001554855-26-001685.md) | [457](/filings/0001554855-26-000876.md) | [421](/filings/0001554855-26-001685.md) |
| Total assets | $m | [262](/filings/0001554855-23-000725.md) | [245](/filings/0001554855-25-000157.md) | [228](/filings/0001554855-24-000334.md) | [215](/filings/0001554855-24-000621.md) | [290](/filings/0001554855-24-000734.md) | [318](/filings/0001554855-26-000300.md) | [304](/filings/0001554855-25-000468.md) | [261](/filings/0001554855-25-000899.md) | [440](/filings/0001554855-25-001920.md) | [435](/filings/0001554855-26-001685.md) | [484](/filings/0001554855-26-000876.md) | [458](/filings/0001554855-26-001685.md) |
| Current liabilities | $m | [46.2](/filings/0001554855-23-000725.md) | [52.0](/filings/0001554855-25-000157.md) | [45.2](/filings/0001554855-24-000334.md) | [54.3](/filings/0001554855-24-000621.md) | [54.8](/filings/0001554855-24-000734.md) | [59.3](/filings/0001554855-26-000300.md) | [82.7](/filings/0001554855-25-000468.md) | [90.2](/filings/0001554855-25-000899.md) | [81.5](/filings/0001554855-25-001920.md) | [125](/filings/0001554855-26-001685.md) | [120](/filings/0001554855-26-000876.md) | [121](/filings/0001554855-26-001685.md) |
| Total liabilities | $m | [59.5](/filings/0001554855-23-000725.md) | [80.3](/filings/0001554855-25-000157.md) | [87.4](/filings/0001554855-24-000334.md) | [109](/filings/0001554855-24-000621.md) | [126](/filings/0001554855-24-000734.md) | [194](/filings/0001554855-26-000300.md) | [228](/filings/0001554855-25-000468.md) | [248](/filings/0001554855-25-000899.md) | [256](/filings/0001554855-25-001920.md) | [311](/filings/0001554855-26-001685.md) | [428](/filings/0001554855-26-000876.md) | [435](/filings/0001554855-26-001685.md) |
| Long-term debt | $m | [11.3](/filings/0001554855-23-000725.md) | [25.8](/filings/0001554855-25-000157.md) | [40.0](/filings/0001554855-24-000334.md) | [52.6](/filings/0001554855-24-000621.md) | [68.3](/filings/0001554855-24-000734.md) | [132](/filings/0001554855-26-000300.md) | [142](/filings/0001554855-25-000468.md) | [154](/filings/0001554855-25-000899.md) | [167](/filings/0001554855-25-001920.md) | [176](/filings/0001554855-26-001685.md) | [296](/filings/0001554855-26-000876.md) | [303](/filings/0001554855-26-001685.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001554855-26-000300.md) | [0.1](/filings/0001554855-25-000468.md) | [0.5](/filings/0001554855-25-000899.md) | [0.8](/filings/0001554855-25-001920.md) | [3.4](/filings/0001554855-26-001685.md) | [3.4](/filings/0001554855-26-000876.md) | [5.7](/filings/0001554855-26-001685.md) |
| Shareholders' equity | $m | [202](/filings/0001554855-24-000734.md) | [165](/filings/0001554855-26-000300.md) | [141](/filings/0001554855-25-001920.md) | [105](/filings/0001554855-25-001920.md) | [164](/filings/0001554855-25-001920.md) | [124](/filings/0001554855-26-001685.md) | [76.1](/filings/0001554855-26-001685.md) | [13.4](/filings/0001554855-26-001685.md) | [184](/filings/0001554855-25-001920.md) | [124](/filings/0001554855-26-001685.md) | [56.1](/filings/0001554855-26-001685.md) | [22.8](/filings/0001554855-26-001685.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(22.4) d](/filings/0001554855-24-000734.md) | [(24.5) d](/filings/0001554855-26-000300.md) | [(35.8)](/filings/0001554855-25-000468.md) | [(30.8) d](/filings/0001554855-25-000899.md) | [(30.7) d](/filings/0001554855-25-001920.md) | [(38.7) d](/filings/0001554855-26-000300.md) | [(24.9)](/filings/0001554855-26-000876.md) | [(55.6) d](/filings/0001554855-26-001685.md) | [(54.0) d](/filings/0001554855-25-001920.md) | [(25.9) d](/filings/0001554855-26-000300.md) | [(68.1)](/filings/0001554855-26-000876.md) | [(47.2) d](/filings/0001554855-26-001685.md) |
| Capital expenditure | $m | [0.0 d](/filings/0001554855-24-000734.md) | [0.0 d](/filings/0001554855-26-000300.md) | [0.1](/filings/0001554855-25-000468.md) | [0.7 d](/filings/0001554855-25-000899.md) | [3.2 d](/filings/0001554855-25-001920.md) | [1.2 d](/filings/0001554855-26-000300.md) | [0.5](/filings/0001554855-26-000876.md) | [1.3 d](/filings/0001554855-26-001685.md) | [6.7 d](/filings/0001554855-25-001920.md) | [4.1 d](/filings/0001554855-26-000300.md) | [0.5](/filings/0001554855-26-000876.md) | [1.1 d](/filings/0001554855-26-001685.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [272](/filings/0001554855-23-000725.md) | [275](/filings/0001554855-24-000334.md) | [276](/filings/0001554855-24-000621.md) | [276](/filings/0001554855-24-000734.md) | [276](/filings/0001554855-25-000468.md) | [276](/filings/0001554855-25-000899.md) | [298](/filings/0001554855-25-001920.md) | [304](/filings/0001554855-26-000876.md) | [304](/filings/0001554855-26-001685.md) | [326](/filings/0001554855-25-001920.md) | [352](/filings/0001554855-26-000876.md) | [352](/filings/0001554855-26-001685.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 348,486,333 at 2026-08-04, from the cover of the [10-Q filed 2026-08-04](/filings/0001554855-26-001685.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.